Global Prevention and Management of Human Papillomavirus Related Diseases: The Pressing Challenges and the Compelling Opportunities

► Prophylactic HPV vaccines are safe, effective and widely implemented.
► Screening is by visual inspection, cytology, HPV DNA tests and disease biomarkers.
► New small molecule inhibitors and immunotherapies for HPV lesions are needed.
► Public education and advocacy for HPV R&D are communal responsibilities.
► Reduction of HPV diseases through stakeholder efforts will be a public health triumph.